AMERISAFE, Inc. (FRA:A3I)
Germany · Delayed Price · Currency is EUR 39.48
-0.34 (-0.85%)
Last updated: Jul 30, 2025
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 50.42 | 55.44 | 62.11 | 55.6 | 65.76 | 86.6 | Upgrade |
Depreciation & Amortization | 0.94 | 1.09 | 1.43 | 1.31 | 1.02 | 1.01 | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.21 | 0 | 0.01 | -0.02 | 0.06 | Upgrade |
Gain (Loss) on Sale of Investments | -5.36 | -7.55 | -4.84 | 11.43 | -5.22 | 2.81 | Upgrade |
Stock-Based Compensation | 3.36 | 2.94 | 1.56 | 2.48 | 2.32 | 3.3 | Upgrade |
Change in Accounts Receivable | -14.92 | -12.06 | -8.49 | 13.39 | 21.66 | 1.19 | Upgrade |
Reinsurance Recoverable | 7.45 | 11.93 | -3.74 | -4.75 | -14.65 | -10.33 | Upgrade |
Change in Accounts Payable | 0.53 | -2.23 | 0.31 | 0.97 | -2.24 | -6.75 | Upgrade |
Change in Unearned Revenue | 10.73 | 5.34 | 1.61 | -6.12 | -8.17 | -11.61 | Upgrade |
Change in Income Taxes | -0.84 | -0.4 | -0.33 | 4.96 | -6.83 | -2.8 | Upgrade |
Change in Insurance Reserves / Liabilities | -39.89 | -22.69 | -22.04 | -49.24 | -15.28 | -12.33 | Upgrade |
Change in Other Net Operating Assets | -2.92 | -8.06 | 2.21 | -0.36 | -2.38 | 9.35 | Upgrade |
Other Operating Activities | 1.18 | 1.4 | 0.63 | -1.14 | 1.27 | 1.66 | Upgrade |
Operating Cash Flow | 9.04 | 24.19 | 29.84 | 28.19 | 37.98 | 63.4 | Upgrade |
Operating Cash Flow Growth | -35.48% | -18.94% | 5.85% | -25.76% | -40.09% | -19.57% | Upgrade |
Capital Expenditures | -1.12 | -0.84 | -0.55 | -2.09 | -1.3 | -0.92 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 0.02 | - | Upgrade |
Investment in Securities | 100.79 | 73.21 | 44.44 | 77.52 | 72.23 | 44.29 | Upgrade |
Investing Cash Flow | 99.67 | 72.37 | 43.88 | 75.43 | 70.96 | 43.37 | Upgrade |
Total Debt Repaid | -0.09 | -0.09 | -0.09 | -0.06 | -0.04 | -0.05 | Upgrade |
Net Debt Issued (Repaid) | -0.09 | -0.09 | -0.09 | -0.06 | -0.04 | -0.05 | Upgrade |
Repurchases of Common Stock | -4.6 | -5.68 | -3.12 | -12.39 | - | - | Upgrade |
Common Dividends Paid | -28.96 | -28.22 | -26.11 | -23.77 | -22.46 | -88.78 | Upgrade |
Financing Cash Flow | -90.86 | -91.2 | -96.51 | -112.87 | -99.97 | -88.83 | Upgrade |
Net Cash Flow | 17.85 | 5.36 | -22.79 | -9.25 | 8.97 | 17.94 | Upgrade |
Free Cash Flow | 7.92 | 23.35 | 29.29 | 26.11 | 36.68 | 62.48 | Upgrade |
Free Cash Flow Growth | -37.62% | -20.28% | 12.20% | -28.84% | -41.29% | -19.70% | Upgrade |
Free Cash Flow Margin | 2.58% | 7.55% | 9.54% | 8.86% | 11.61% | 18.40% | Upgrade |
Free Cash Flow Per Share | 0.41 | 1.22 | 1.52 | 1.35 | 1.89 | 3.23 | Upgrade |
Cash Income Tax Paid | 11.75 | 11.75 | 13.95 | 7.79 | 18.2 | 20.56 | Upgrade |
Levered Free Cash Flow | 78.41 | 43.28 | 53.94 | 94.47 | 32.19 | 56.98 | Upgrade |
Unlevered Free Cash Flow | 78.41 | 43.28 | 53.94 | 94.47 | 32.19 | 56.98 | Upgrade |
Change in Net Working Capital | -35.7 | 3.08 | -3.15 | -50.49 | 19.51 | 13.23 | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.